K Y Permyakova
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 5
Publications (10 Years): 5
Top Venues
Publications
- Ekaterina I Lesnova, Olga V Masalova, K Y Permyakova, Natalya A Demidova, Vladimir T Valuev-Elliston, Alexander V Ivanov, Vladimir T Valuev-EllistonThe adjuvant effect of polymuramil, a NOD1 and NOD2 agonist, differs when immunizing mice of different inbred lines with nonstructural hepatitis C virus (Flaviviridae: Hepacivirus )proteins and is synergistically enhanced in combination with pyrogenalum, a TLR4 agonist. Voprosy virusologii 68 (4) (2023)
- Ekaterina I Lesnova, Olga V Masalova, K Y Permyakova, Natalya A Demidova, Vladimir T Valuev-Elliston, Alexander V Ivanov, Vladimir T Valuev-EllistonThe adjuvant effect of polymuramil, a NOD1 and NOD2 agonist, differs when immunizing mice of different inbred lines with nonstructural hepatitis C virus (Flaviviridae: Hepacivirus )proteins and is synergistically enhanced in combination with pyrogenalum, a TLR4 agonist. Voprosy virusologii 68 (4) (2023)
- Ekaterina I Lesnova, Olga V Masalova, K Y Permyakova, Natalya A Demidova, Vladimir T Valuev-Elliston, Alexander V Ivanov, Vladimir T Valuev-EllistonThe adjuvant effect of polymuramil, a NOD1 and NOD2 agonist, differs when immunizing mice of different inbred lines with nonstructural hepatitis C virus (Flaviviridae: Hepacivirus )proteins and is synergistically enhanced in combination with pyrogenalum, a TLR4 agonist. Voprosy virusologii 68 (4) (2023)
- Olga V Masalova, Ekaterina I Lesnova, Sergey M Andreev, Nadezhda Shershakova, Vyacheslav V Kozlov, K Y Permyakova, Natalya A Demidova, Vladimir T Valuev-Elliston, E A Turetskiy, Alexander V Ivanov, T N Nikolaeva, M R Khaitov, Alexander V Pronin, Vladimir T Valuev-Elliston
- Ekaterina I Lesnova, Olga V Masalova, K Y Permyakova, Natalya A Demidova, Vladimir T Valuev-Elliston, Alexander V Ivanov, Vladimir T Valuev-EllistonThe adjuvant effect of polymuramil, a NOD1 and NOD2 agonist, differs when immunizing mice of different inbred lines with nonstructural hepatitis C virus (Flaviviridae: Hepacivirus )proteins and is synergistically enhanced in combination with pyrogenalum, a TLR4 agonist. Voprosy virusologii 68 (4) (2023)